A Quiet Shift in the American Childhood Vaccine Debate
The U.S. childhood vaccine schedule is undergoing its most significant reassessment in decades after President Trump ordered a full review comparing American practices to countries with far fewer recommended doses. Concerns over cumulative exposure, aluminum adjuvants, and long-term safety gaps have pushed the debate into mainstream policy discussions, raising new questions about how the U.S. became an international outlier and whether the schedule’s density is scientifically justified.
